vs
Lucid Group, Inc.（LCID）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Lucid Group, Inc.的1.2倍（$622.0M vs $522.7M），Royalty Pharma plc净利率更高（34.4% vs -155.7%，领先190.2%），Lucid Group, Inc.同比增速更快（122.9% vs 4.8%），过去两年Lucid Group, Inc.的营收复合增速更高（74.0% vs 4.6%）
Lucid Group, Inc.是总部位于美国加利福尼亚州纽瓦克的汽车科技企业，专注于电动汽车制造及先进电动汽车动力系统供应。2021年9月，公司在亚利桑那州卡萨格兰德的工厂开始生产Lucid Air豪华轿车，第二款车型Lucid Gravity SUV于2024年12月投产，同时也为阿斯顿·马丁等其他车企供应和研发动力总成技术。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
LCID vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.2倍
$522.7M
营收增速更快
LCID
高出118.2%
4.8%
净利率更高
RPRX
高出190.2%
-155.7%
两年增速更快
LCID
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $522.7M | $622.0M |
| 净利润 | $-814.0M | $214.2M |
| 毛利率 | -80.7% | — |
| 营业利润率 | -203.7% | 62.4% |
| 净利率 | -155.7% | 34.4% |
| 营收同比 | 122.9% | 4.8% |
| 净利润同比 | -104.9% | 2.9% |
| 每股收益（稀释后） | $-8.26 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LCIDRPRX
| Q4 25 | $522.7M | $622.0M | ||
| Q3 25 | $336.6M | $609.3M | ||
| Q2 25 | $259.4M | $578.7M | ||
| Q1 25 | $235.0M | $568.2M | ||
| Q4 24 | $234.5M | $593.6M | ||
| Q3 24 | $200.0M | $564.7M | ||
| Q2 24 | $200.6M | $537.3M | ||
| Q1 24 | $172.7M | $568.0M |
净利润LCIDRPRX
| Q4 25 | $-814.0M | $214.2M | ||
| Q3 25 | $-978.4M | $288.2M | ||
| Q2 25 | $-539.4M | $30.2M | ||
| Q1 25 | $-366.2M | $238.3M | ||
| Q4 24 | $-397.2M | $208.2M | ||
| Q3 24 | $-992.5M | $544.0M | ||
| Q2 24 | $-643.4M | $102.0M | ||
| Q1 24 | $-680.9M | $4.8M |
毛利率LCIDRPRX
| Q4 25 | -80.7% | — | ||
| Q3 25 | -99.1% | — | ||
| Q2 25 | -105.0% | — | ||
| Q1 25 | -97.2% | — | ||
| Q4 24 | -89.0% | — | ||
| Q3 24 | -106.2% | — | ||
| Q2 24 | -134.5% | — | ||
| Q1 24 | -134.3% | — |
营业利润率LCIDRPRX
| Q4 25 | -203.7% | 62.4% | ||
| Q3 25 | -279.9% | 70.1% | ||
| Q2 25 | -309.5% | 36.3% | ||
| Q1 25 | -294.4% | 94.0% | ||
| Q4 24 | -312.6% | 60.9% | ||
| Q3 24 | -385.2% | — | ||
| Q2 24 | -392.6% | 50.2% | ||
| Q1 24 | -422.6% | -13.0% |
净利率LCIDRPRX
| Q4 25 | -155.7% | 34.4% | ||
| Q3 25 | -290.7% | 47.3% | ||
| Q2 25 | -207.9% | 5.2% | ||
| Q1 25 | -155.8% | 41.9% | ||
| Q4 24 | -169.4% | 35.1% | ||
| Q3 24 | -496.1% | 96.3% | ||
| Q2 24 | -320.8% | 19.0% | ||
| Q1 24 | -394.2% | 0.8% |
每股收益（稀释后）LCIDRPRX
| Q4 25 | $-8.26 | $0.49 | ||
| Q3 25 | $-3.31 | $0.67 | ||
| Q2 25 | $-0.28 | $0.07 | ||
| Q1 25 | $-0.24 | $0.55 | ||
| Q4 24 | $-0.20 | $0.46 | ||
| Q3 24 | $-0.41 | $1.21 | ||
| Q2 24 | $-0.34 | $0.23 | ||
| Q1 24 | $-0.30 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.6B | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $717.3M | $9.7B |
| 总资产 | $8.4B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资LCIDRPRX
| Q4 25 | $1.6B | $618.7M | ||
| Q3 25 | $2.3B | $938.9M | ||
| Q2 25 | $2.8B | $631.9M | ||
| Q1 25 | $3.6B | $1.1B | ||
| Q4 24 | $4.0B | $929.0M | ||
| Q3 24 | $3.5B | $950.1M | ||
| Q2 24 | $3.2B | $1.8B | ||
| Q1 24 | $4.0B | $843.0M |
总债务LCIDRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益LCIDRPRX
| Q4 25 | $717.3M | $9.7B | ||
| Q3 25 | $1.8B | $9.6B | ||
| Q2 25 | $2.4B | $9.5B | ||
| Q1 25 | $3.2B | $9.8B | ||
| Q4 24 | $3.9B | $10.3B | ||
| Q3 24 | $2.7B | $10.3B | ||
| Q2 24 | $3.5B | $9.8B | ||
| Q1 24 | $4.2B | $9.9B |
总资产LCIDRPRX
| Q4 25 | $8.4B | $19.6B | ||
| Q3 25 | $8.8B | $19.3B | ||
| Q2 25 | $8.9B | $18.3B | ||
| Q1 25 | $9.2B | $17.6B | ||
| Q4 24 | $9.6B | $18.2B | ||
| Q3 24 | $8.5B | $18.0B | ||
| Q2 24 | $8.2B | $17.7B | ||
| Q1 24 | $8.9B | $16.1B |
负债/权益比LCIDRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-916.4M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-1.2B | — |
| 自由现金流率自由现金流/营收 | -237.6% | — |
| 资本支出强度资本支出/营收 | 62.3% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $-3.8B | — |
8季度趋势，按日历期对齐
经营现金流LCIDRPRX
| Q4 25 | $-916.4M | $827.1M | ||
| Q3 25 | $-756.6M | $702.6M | ||
| Q2 25 | $-830.2M | $364.0M | ||
| Q1 25 | $-428.6M | $596.1M | ||
| Q4 24 | $-533.1M | $742.5M | ||
| Q3 24 | $-462.8M | $703.6M | ||
| Q2 24 | $-507.0M | $658.2M | ||
| Q1 24 | $-516.7M | $664.6M |
自由现金流LCIDRPRX
| Q4 25 | $-1.2B | — | ||
| Q3 25 | $-955.5M | — | ||
| Q2 25 | $-1.0B | — | ||
| Q1 25 | $-589.9M | — | ||
| Q4 24 | $-824.8M | — | ||
| Q3 24 | $-622.5M | — | ||
| Q2 24 | $-741.3M | — | ||
| Q1 24 | $-714.9M | — |
自由现金流率LCIDRPRX
| Q4 25 | -237.6% | — | ||
| Q3 25 | -283.9% | — | ||
| Q2 25 | -390.4% | — | ||
| Q1 25 | -251.0% | — | ||
| Q4 24 | -351.8% | — | ||
| Q3 24 | -311.2% | — | ||
| Q2 24 | -369.6% | — | ||
| Q1 24 | -413.9% | — |
资本支出强度LCIDRPRX
| Q4 25 | 62.3% | — | ||
| Q3 25 | 59.1% | — | ||
| Q2 25 | 70.4% | — | ||
| Q1 25 | 68.6% | — | ||
| Q4 24 | 124.4% | — | ||
| Q3 24 | 79.8% | — | ||
| Q2 24 | 116.8% | — | ||
| Q1 24 | 114.7% | — |
现金转化率LCIDRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LCID
| LCNRV | $287.2M | 55% |
| Other | $80.4M | 15% |
| Related Party | $74.4M | 14% |
| Regulatory Credits | $34.2M | 7% |
| Warranty Provision | $26.2M | 5% |
| Sale And Leaseback Transactions | $15.2M | 3% |
| Other International | $5.0M | 1% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
